What is the TCS-DXC technology case?

It is a trade-secret lawsuit in the US between Tata Consultancy Services (TCS) and US-based Computer Sciences Corporation (CSC), now part of DXC Technology.

Since the mid-1990s, CSC has licenced core life-insurance software to the US insurer Transamerica, under agreements signed in 1994 and 1998, later amended in 1999 to add the CyberLife platform and in 2005 to add Vantage. In 2013, Transamerica hired TCS to maintain these CSC systems, and in 2016–18 TCS bid for, and then won, a large modernisation deal using its own BaNCS platform.

CSC has alleged that TCS, while working for Transamerica, got access to CSC’s confidential material (including source code and technical manuals) and used that information to (a) win a $2.6-billion contract from Transamerica in 2018 and (b) speed up the development of BaNCS for the US market.

In August 2019, CSC sued TCS under the US Defend Trade Secrets Act. In November 2023, after an eight-day trial, a US district court found TCS liable for misappropriation of CSC’s trade secrets and granted both monetary damages and a wide injunction restricting TCS’s use of BaNCS software built with the disputed material.

What has the US Court of Appeals ruled in this case recently?

On November 21, 2025, the US Court of Appeals for the Fifth Circuit largely upheld the district court’s decision against TCS.

1) The appellate court agreed that TCS’s use of CSC’s confidential information was not authorised by the relevant contracts and that TCS misappropriated that information under the trade-secret law.

2) The district court had awarded about $56 million in compensatory (unjust-enrichment) damages and $112 million in exemplary (punitive) damages; the appeals court retained those awards. .

3) It vacated the existing injunction and sent the case back to the district court to issue a narrower, revised injunction consistent with its guidance, instead of the very broad earlier restrictions on BaNCS and certain TCS personnel.

TCS, in its exchange filing, characterised this as an “adverse ruling” that confirms the district court decision on damages, while noting that the injunction has been vacated and must be reassessed.

Media reports have described the total financial impact as roughly $194 million, possibly combining the damages with interest, fees and costs. The court documents themselves specify $56 million in compensatory and $112 million in exemplary damages; any additional impact from interest, fees and costs is not quantified in the judgment or TCS’s filing.

What will be the implication of the ruling on TCS’ financials?

From an accounting and P&L perspective, there are three main points to consider.

1) A confirmed obligation, unless later overturned: The appeals court has confirmed TCS’s liability for the damages awarded by the district court, subject only to any further successful review (for example, rehearing or a higher-court appeal).

2) Need for provisions in the books: In its exchange filing, TCS says “necessary provisions related to this matter will be duly made in the books of accounts and financial statements in accordance with applicable accounting standards.” In plain terms, that means TCS will either create or adjust a provision (an accounting reserve) so that its balance sheet reflects the expected outflow. If some provision was already made earlier, only the shortfall will now be recognised.

3) Financial impact magnitude vs TCS’s size: Relative to TCS’s annual profits, the financial impact looks like a one-time, low single-digit percentage hit. The cash outflow, when it happens, will still be material in absolute rupee terms and may show up as an exceptional item or legal expense, but it does not change the basic solvency or going-concern position of the company.

A further nuance is that if TCS continues to challenge the ruling, there can be timing differences between when the provision is booked and when cash is actually paid. That timing will depend on how long any further legal processes run and whether the parties ever settle.

Does it dent the credibility of the TCS brand?

Investors have to separate legal liability from market perception. On the legal side, two US courts (trial and appeal) have now held that TCS misappropriated CSC/DXC’s trade secrets in this matter, and the district court’s finding that the conduct was ‘willful and malicious’ for purposes of exemplary damages has been left intact on appeal.

On the communication side, TCS continues to state that it will “vigorously defend its position” and is considering further review/appeal.

TCS has been ranked among the 100 most valuable brands worldwide in the Kantar BrandZ Most Valuable Global Brands 2025 Report. For a brand of TCS’s size, which sells trust-based, long-duration technology relationships, repeated adverse findings on trade-secret use are reputationally uncomfortable. The electronic health records giant Epic Systems case earlier (where US courts ultimately confirmed large damages against TCS in another trade-secret dispute) is already on the record.

That said, global clients are usually pragmatic. They look at the company’s delivery record, security posture, and remediation steps, not just one litigation. The financial scale of this award, while large, is not crippling for TCS and is unlikely by itself to make clients walk away en masse.

However, for some risk-sensitive clients (especially in regulated sectors like healthcare and financial services), procurement and legal teams are likely to look more closely at TCS’s internal controls around third-party IP, rebadged employees and platform development.

So to be fair, this ruling adds a reputational blemish and heightens scrutiny, but it does not by itself cripple the TCS brand. The bigger issue is what TCS does next on governance, compliance and communication to reassure customers and investors.

Are such digressions common within the IT sector? What signal is it sending for players in this segment?

Serious trade-secret verdicts of this size against top-tier IT service firms are not routine, but IP disputes themselves are quite common in global software and services. Vendors constantly work on client systems, see proprietary code and processes, and at the same time try to build their own reusable platforms and tools. That overlap is exactly where trade-secret law bites if controls are weak or if staff treat “learning from a client” and “copying a client” as the same thing.

In recent memory, a curious legal battle erupted between two IT service giants namely, Cognizant and Infosys in August 2024 when Cognizant’s subsidiary, TriZetto, sued Infosys for allegedly misusing trade secrets to build a competing healthcare platform (Helix). But cases like Epic vs TCS and now CSC/DXC vs TCS send some clear messages to the sector.

One, courts will look through “service provider” contracts. In this case, the Fifth Circuit emphasised that TCS’s contractual access to CSC’s software was limited to work done “solely for the benefit” of Transamerica, and not for developing a competing platform or winning new business. In simple words, you had access to your client’s vendor’s system to run it, not to clone it.

Two, internal policies are no use if not followed. The court noted that TCS’s own IP manual required it to secure proper licences before using third-party IP, and noted that TCS employees neither sought CSC’s consent nor clarified the limits of use, despite repeated letters from CSC warning about possible misappropriation.

Three, rebadging (transferring client staff onto vendor’s payroll, unchanged roles) and large platform deals are a compliance minefield. The case turned, in part, on how rebadged Transamerica employees and TCS’s BaNCS team handled CSC materials (such as source code and technical manuals) while TCS was both maintaining CSC systems and building BaNCS.

For the broader IT industry, the signal is that learning from client systems must be tightly policed. Vendors need clear do-and-don’t rules, logs, approvals and audits when staff move from client-owned platforms to in-house product teams. Boards and CEOs cannot treat trade-secret disputes as routine cost of doing business. Repeat findings will push up legal risk premia, affect negotiations and may even influence how clients allocate complex transformation work between “staff augmentation” and “platform plus services” models.

So, while this kind of litigation is not unique to TCS, the combination of repeated high-profile trade-secret cases and large US damages is a warning shot for all IT services and SaaS firms that blend client work with their own product-building.

Published on November 25, 2025